| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Chief Financial Officer | Stock Option (right to buy) | 194,250 | 13 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 13 Feb 2025 | 1 | $0 | 4 | Chief Financial Officer | 18 Feb 2025, 16:30 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 15 Sep 2024 | 1 | $0 | 4 | Chief Financial Officer | 17 Sep 2024, 17:01 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 25 Apr 2023 | 1 | $0 | 4 | Chief Financial Officer | 27 Apr 2023, 16:30 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 30 Sep 2022 | 1 | +$83,000 | 4 | Chief Financial Officer | 03 Oct 2022, 17:01 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 30 Jun 2022 | 1 | +$60,670 | 4 | Chief Financial Officer | 30 Jun 2022, 17:52 |